Skip to search formSkip to main contentSkip to account menu

AP 1903 reagent

Known as: AP-1903, AP1903 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Organic ChemicalsRimiducid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Abstract 3157: Novel GD2-specific chimeric antigen receptor-modified T cells targeting osteosarcoma
Despite intensive multi-modality therapies employed in the treatment of osteosarcoma (OS) the prognosis for children with high… 
2011
2011
Results of a phase I/II clinical trial of BPX-101, a novel drug-activated dendritic cell (DC) vaccine for metastatic castration-resistant prostate cancer (mCRPC).
4670 Background: We report results of a phase I/II clinical trial of BPX-101, a drug-activated autologous DC vaccine targeting… 
2011
2011
Long-term regulation of genetically modified primary hematopoietic cells in dogs.
We report long-term results from a large animal model of in vivo selection. Nine years ago, we transplanted two dogs (E900 and… 
2011
2011
Antigen-specific immunity and tumor inflammation after vaccination with BPX-101, a drug-activated dendritic cell vaccine for metastatic castration-resistant prostate cancer (mCRPC).
176 Background: We report evidence of antigen-specific immunity and severe prostate cancer inflammation and necrosis after… 
2011
2011
Results of a phase I/II clinical trial of BPX-101, a novel drug-activated dendritic cell (DC) vaccine for metastatic castration-resistant prostate cancer (mCRPC).
132 Background: We report results of a phase I/II clinical trial of BPX-101, a drug- activated autologous DC vaccine targeting… 
2011
2011
Correlation of serum cytokines with clinical responses in patients treated with BPX-101, a drug-activated vaccine for metastatic castration-resistant prostate cancer (mCRPC).
167 Background: We report the correlation of clinical and immune monitoring results for subjects enrolled in a phase I/IIa… 
2011
2011
Suicide Genes Breathe New Life into Cell Therapies
A suicide gene can kill harmful alloreactive donor T cells in patients undergoing stem cell transplantation for relapsed acute… 
2010
2010
Abstract 4761: The iCD40. MyD88 combo-vector: A new platform for enhanced DC tumor immunotherapy
Introduction: Given the pre-eminent role of dendritic cells (DCs) as antigen-presenting cells, their exploitation as natural… 
2010
2010
Abstract LB-80: Correlation of serum cytokines with clinical responses in patients treated with BPX-101, a novel dendritic cell vaccine for metastatic castration resistant prostate cancer (mCRPC)
Background: We report interim clinical and immune monitoring results for the low dose cohort of patients enrolled in an ongoing… 
2003
2003
Regulation of gene expression by synthetic dimerizers with novel specificity.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)